Amid tariff turmoil, Novartis commits to spending $23B on U.S. manufacturing

Amid tariff turmoil, Novartis commits to spending $23B on U.S. manufacturing

Source: 
BioPharma Dive
snippet: 

Novartis will substantially expand its U.S. footprint, announcing Thursday plans to spend $23 billion over five years to build six new factories, expand three existing ones and add a new research and development hub.